Invited Speakers
Speakers at ITQB-UNL
John G. Aunins
Merck Sharp & Dohme, West Point, New Jersey, USA
Some Perspectives on Vaccines, Biologicals, and the Pharmaceutical Industry
November 15th 2011
Uwe Marx & Mark Rosowski
Technische Universität Berlin, Institute of Biotechnology - Department of Medical Biotechnology
Vascularized multi-organ systems - the next level of engineering human biology in vitro
August 4th 2011
Isabelle Knott
Director, Head of Cell Culture Development
GlaxoSmithKline Biologicals S.A., Rixensart, Belgium
Cervarix: first human vaccine manufactured with baculovirus expression system
July 12th 2011
Héla Kallel
Head, Bioprocess Development Unit
Institut Pasteur de Tunis - 13, place Pasteur. BP 74. 1002 Tunis
Bioprocess development activities at Institut Pasteur of Tunis
June 28th 2011
Christian Manzke & Etienne Evrard MD
Sartorius Stedim Biotech GmbH - B. Braun AG -Goettingen / Melsungen
Bioprocess integrated solutions
Abril 27th 2011
Brian Lee MD
President, PBS Biotech, Inc
PBS Biotech, Inc - California, EUA
Mixing methodologies in single use bioreactors - A comparative analysis of consistency across scale
Abril 4th 2011
Aleš Štrancar MD
BIA Separations, Teslova 30, SI-1000 Ljubljana
Monolithic chromatography supports - technology platform for the analysis and production of new generation of drug candidates like plasmid DNA and viral vector particles
March 21st 2011
Wilfried Bakker MD
Netherlands Vaccine Institute (NVI/RIVM)
Development and Technology Transfer for Viral Vaccines
March 15th 2011
Marc Peschanski MD
Scientific Director, Institute for Stem Cell Therapy and Exploration of Monogenic Diseases (I-STEM, INSERM/UEVE) Evry, France
Pathological modeling, drug discovery and toxicity testing using pluripotent stem cells
March 2nd 2011
Leo van der Pol MD
Overview of Vaccine Process Development at RIVM
2011
Nigel Jenkins
National Institute for Cellular Biotechnology, Ireland
Quality considerations for the production of biopharmaceuticals
February 2nd 2010
Hagen von Briesen
Fraunhofer-Institute for Biomedical Engineering
Global HIV Vaccine Research Cryorepository - GHRC
January 29th 2010
Judy Lieberman
Immune Disease Institute and Program in Cellular and Molecular Medicine, Children's Hospital
Boston, Dept of Pediatrics, Harvard Medical School
Micromanaging cell growth and differentiation
December 16th, 2009
Octavio T. Ramírez
Departamento de Medicina Molecular y Bioprocesos, Instituto de Biotecnología Universidad Nacional
Autónoma de México
Bioreactor Scale-Down Studies of Temperature-Inducible Recombinant Protein Production in E. coli
November 23th, 2009
Kenneth Lundstrom
PanTherapeutics, Lausanne, Switzerland
Viral Vectors in Gene Therapy: Special Emphasis on Alphaviruses
March 11th, 2009
Kenneth Lundstrom
PanTherapeutics, Lausanne, Switzerland
Expression of GPCRs in Drug Discovery and Structural Biology
March 10th, 2009
Catherine Brenner Jan, DR CNRS
Faculté de Pharmacie, Université Paris-Sud
Signalisation et physiopathologie cardiaque INSERM U769
February 2009
Anna Price
In vitro Toxicology Unit, European Centre for the Validation of Alternative Methods, Institute of Health and Consumer Protection, European Commission Joint Research Centre, Ispra (VA), Italy
Re-aggregated brain cell culture as a sensitive in vitro model to evaluate developmental/adult neurotoxicity: application for regulatory requirements
October 28th, 2008
Dr. Ing. Reiner Luttmann
Hamburg University of Applied Sciences, Research Center of Bioprocess Engineering and Analytical Techniques
A comprehensive study in optimal production of Active Pharmaceutical Ingredients with Pichia pastoris
September 12th, 2008
Manuel Cánovas
Department of Biochemistry and Molecular Biology B. Faculty of Chemistry. University of Murcia
Bioprocess Optimization By Using Systems Biology
September 11th, 2008
Matthew Croughan
Amgen Bioprocessing Center
Keck Graduate Institute (KGI), Claremont, CA
The Silver Anniversary of Clinical Protein Production from Recombinant CHO Cell Culture
June 9th, 2008
Carlos A. Pereira
Univ. Strasbourg, França and Instituto Butantan, Brasil
Approaches for preparation of viral antigens from mammalian and insect cells
John Aunins
MERCK & CO, Philadelphia, EUA and ITQB/UNL, Portugal
Adenovirus-vectored HIV vaccine development
Hansjörg Hauser
GBF and Univ. Braunschweig, Germany
Cancer immune therapy using genetically modified dendritic cells
Eric J. Kremer
CNRS-UMR, France
Ursula Sonnewald
Pharmacology & Toxicology Medical School Trondheim, Norway
Uwe Gottschalk
Sartorius AG, Germany
Heiko Zimmermann
Fraunhofer IBMT, Germany
Catherine Brenner
CNRS-UMR, France
Kenneth Lundstrom
PanTherapeutics,Switzerland
Brian Kelley
Genentech, USA
Laura Palomares
México
